Welcome to our Media library
Access a range of clinical educational content, to all the clinical content available about for both macula and peripheral treatments, including: clinical articles, clinical videos, treatment guidelines…
SEARCH
Advanced search
TYPE OF DOCUMENTS
FILTERS
TREATMENT
TYPE OF DOCUMENTS
From first-line to refractory: Integrating SLT and SubCyclo
22/01/2026
The “drops first, everything else later” era is coming to an end. Dr Mark Chiang (Australia) shares his laser-first approach to glaucoma management: SLT to match first-line drop efficacy without the burden of daily medication, SubCyclo for patients who fail or cannot tolerate earlier treatments, and stents for the right surgical candidates.
Could we vs. Should we? The 6-year evidence for First-Line SLT
22/01/2026
The “drops first, everything else later” approach to glaucoma is being challenged. In this video, Prof. Gus Gazzard shares six-year LiGHT data showing that first-line SLT kept most eyes at target intraocular pressure without long-term drops, reduced the need for trabeculectomy, and delivered better visual field preservation compared with a drops-first approach.
Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial 3- and 6-year study results summary
14/05/2025
Summary of the 3- and 6-year study results of the LiGHT study.
Glaucoma & Dry Eye: A patient-centered approach with SLT & IPL
17/03/2025
Discover our podcast produced for World Glaucoma Week 2025 in which Professor Mario de La Torre presents the diagnostic and therapeutic management of a 65-year-old male patient with Primary Open-Angle Glaucoma and Dry Eye Syndrome. He was treated with Selective Laser Trabeculoplasty (SLT) for long-term IOP control and Intense Pulsed Light (IPL) therapy to restore ocular surface health. This combined approach improved both glaucoma management and patient comfort.
SLT as first-line therapy for POAG & OH – Prof. Gus Gazzard
27/02/2024
In this interview, Prof. Gus Gazzard explains how SLT can be the first-line therapy for all open angle, glaucoma and ocular hypertension.
Overcoming barriers to SLT as first line therapy for POAG & OH – Prof. Gus GAZZARD
12/10/2023
In this video, Prof. Gus GAZZARD , explains how to overcome barriers to SLT as first line therapy for POAG & OH. This video is from our symposium held at ESCRS 2023.
Selective Laser Trabeculoplasty as a First-line Treatment
17/05/2023
The glaucoma surgical landscape is evolving and changing dramatically as we move forward in the era of interventional glaucoma. The interventional glaucoma mindset represents a significant paradigm shift in patient care, taking the treatment burden out of the patient’s hands and placing more emphasis on earlier laser intervention.
SLT: Positive implications from the LiGHT study
07/03/2023
Glaucoma is a lifelong disease that requires continual monitoring and management. For many patients, glaucoma can be controlled medically—at least for a time—but the treatment is far from perfect. Complications, side effects, and compliance are common issues for those who rely on eye drops to control IOP. Other barriers to medical treatment include nonresponse to a medication, tachyphylaxis, and financial burden.
SLT laser treatment for glaucoma – Paul Singh, MD
05/01/2023
In this interview, Inder Paul Singh, MD, explains the interest of using SLT as first line therapy for glaucoma instead of medication and the impact on the ocular surface.
"SLT not only takes away the compliance issues that are so difficult for us but it actually addresses the pathology directly."